Monish Ram Makena

8PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsPredictive and prognostic markersRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 13, 2023
Rethinking Oncologic Treatment Strategies with Interleukin-2.

Brian Ko, Naoko Takebe, Omozusi Andrews

|Aug 19, 2021
ALT neuroblastoma chemoresistance due to telomere dysfunction-induced ATM activation is reversible with ATM inhibitor AZD0156.

Balakrishna Koneru, Ahsan Farooqi, Thinh H Nguyen

|Jan 15, 2021
Epigenetic Modulation of SPCA2 Reverses Epithelial to Mesenchymal Transition in Breast Cancer Cells.

Monish Ram Makena, Myungjun Ko, Donna Kimberly Dang

|Sep 06, 2019
Fenretinide via NOXA Induction, Enhanced Activity of the BCL-2 Inhibitor Venetoclax in High BCL-2-Expressing Neuroblastoma Preclinical Models.

Thinh H Nguyen, Balakrishna Koneru, Sung-Jen Wei

|Sep 05, 2019
Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance.

Monish Ram Makena, Himavanth Gatla, Dattesh Verlekar

|May 12, 2019
A Ca2+-ATPase Regulates E-cadherin Biogenesis and Epithelial-Mesenchymal Transition in Breast Cancer Cells.

Donna K Dang, Monish Ram Makena, José P Llongueras

Pageof 2

Frequent Collaborators

2 joint publications

Rajini Rao

2 joint publications

Wan Hsi Chen

2 joint publications

C Patrick Reynolds

1 joint publications

Siddhartha Yavvari